IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading Regulation), 2015'.
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
NCVI Enterprises Limited, part of the promoter group of IOL Chemicals and Pharmaceuticals, bought 7,00,000 equity shares of the company on the open market on 18 March 2026. Following this purchase, the promoter group's holding through NCVI Enterprises increased from 4,75,50,695 shares (16.20%) to 4,82,50,695 shares (16.44%). The transaction was disclosed under Regulation 7(2) of SEBI's Insider Trading Regulations, and the company informed both NSE and BSE about it on 19 March 2026. No derivative trading was involved in this transaction.
This is a small open-market purchase by a promoter group entity (about 0.24% increase in their holding), which is generally viewed as a mildly positive signal of insider confidence in the company. However, the size of the acquisition is modest and unlikely to materially move the stock price.